AstraZeneca's Three-in-One COPD Inhaler Succeeds in Phase III Trial Post author:Sam Post published:January 25, 2018 Post category:BioPharma Astra has Glaxo and its COPD treatment Trelegy Ellipta squarely in its sights. Source: BioSpace You Might Also Like <b>Virginia C. Drosos</b>, President Of Assurex Health, Receives The EY Entrepreneur Of The Year 2017 Award In Ohio Valley Region June 18, 2017 Pressure BioSciences, Inc. Achieves CE Marking For Its Next Generation Sample Preparation Instrument, The Barocycler 2320EXTREME February 1, 2017 Eagle Pharma To Discuss First Quarter 2017 Financial Results On May 8, 2017 April 24, 2017
<b>Virginia C. Drosos</b>, President Of Assurex Health, Receives The EY Entrepreneur Of The Year 2017 Award In Ohio Valley Region June 18, 2017
Pressure BioSciences, Inc. Achieves CE Marking For Its Next Generation Sample Preparation Instrument, The Barocycler 2320EXTREME February 1, 2017
